The journey to global market access for innovative therapies is fraught with challenges that vary significantly across the world. Drug manufacturers must adeptly navigate ever-changing regulatory ...
The outlook for drug development to treat rare diseases looks encouraging, offering hope to the 300 million people globally facing the significant challenges of these often-overlooked conditions.